Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01176617 · ClinicalTrials.gov registry record · NA
Assessing Arrhythmias After Ablation Using Implantable Recorders
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01176617: Completed NA study, sponsored by University of Pennsylvania.
NCT01176617 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01176617, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if continuous monitoring using an implantable loop recorder (ie. a device that is placed just underneath the skin of the chest and monitors the heart rate and rhythm) for a year long period after atrial fibrillation ablation may be superior to the current conventional monitoring strategy used by us for determination of atrial fibrillation recurrence (ie. return of the abnormal heart rhythm) and/or arrythmia burden (ie. how long the abnormal rhythm continues or how often the rhythm occurs). Some data suggests that continuous monitoring over longer periods may be better in identifying recurrence of atrial fibrillation after ablation and thus assist in its overall management. The device being used for this study is the Reveal XT, which, is currently FDA approved for monitoring all varieties of cardiac rhythm disorders including atrial fibrillation.
Interventions
- DEVICE Reveal XT implantable loop recorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01176617
The ClinicalTrials.gov registry entry for NCT01176617 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reveal XT implantable loop recorder is the first listed.
NCT01176617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01176617 about?
NCT01176617 is a clinical study titled "Assessing Arrhythmias After Ablation Using Implantable Recorders". The purpose of this study is to determine if continuous monitoring using an implantable loop recorder (ie. a device that is placed just underneath the skin of the chest and monitors the heart rate and rhythm) for a year long period after atrial fibrillation ablation may be superior to the current co...
What is the current status of trial NCT01176617?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2012-06. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01176617?
The interventions under investigation include: Reveal XT implantable loop recorder (DEVICE).
Who is sponsoring clinical trial NCT01176617?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.